Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FormerXBC Inc XEBEQ

Xebec Adsorption Inc designs, engineers, and manufactures products that are used for purification, separation, dehydration, and filtration equipment for gases and compressed air. The company operates in three reportable segments: Systems, Corporate and other, and Support. Its product lines are natural gas dryers for natural gas refueling stations, compressed gas filtration, biogas purification, associated gas, engineering services, and air dryers. The company's geographical segments are United States, Canada, China, Other, Korea, Italy, and France.


GREY:XEBEQ - Post by User

Comment by bmo1212on Jan 17, 2021 8:03pm
208 Views
Post# 32316576

RE:TAM for Oxygen?

RE:TAM for Oxygen?The global oxygen therapy market size was estimated at USD 7.09 billion in 2015 and is anticipated to grow at a CAGR of 11.1% over the forecast period. Increasing incidences of chronic respiratory diseases coupled with rising demand for home healthcare are the major drivers of the market.
The global oxygen therapy market is expected to grow at a compound annual growth rate of 11.7% from 2019 to 2026 to reach USD 23.2 billion by 2026.
North America dominated the oxygen therapy market with a share of 28.9% in 2019. This is attributable to high R&D investments and trials pertaining to oxygen therapy.

<< Previous
Bullboard Posts
Next >>